6-hydroxydopamine drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| 6-hydroxydopamine | associated_with | Parkinson’s disease | — | 1 |
Mentioned in (12)
Papers in which this entity is mentioned.
- High-Parameter Spatial Multi-Omics through Histology-Anchored Integration (2025)
- Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. (2021)
- TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease. (2020)
- Refinement of learned skilled movement representation in motor cortex deep output layer. (2017)
- Induced neuronal reprogramming. (2014)
- Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases? (2014)
- Prenatal ethanol exposure disrupts intraneocortical circuitry, cortical gene expression, and behavior in a mouse model of FASD. (2013)
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. (2011)
- Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. (2010)
- Brain stress systems in the amygdala and addiction. (2009)
- Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. (2008)
- Causes and consequences of methamphetamine and MDMA toxicity. (2006)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| 6-hydroxydopamine | drug | 10 | 13 |
| 6-ohda | drug | 4 | 17 |